MedAdvisor Limited (MDR.AX)
- Previous Close
0.3050 - Open
0.2950 - Bid 0.2900 x 8000000
- Ask 0.3000 x 6828800
- Day's Range
0.2850 - 0.2950 - 52 Week Range
0.1600 - 0.3450 - Volume
162,929 - Avg. Volume
418,458 - Market Cap (intraday)
162.296M - Beta (5Y Monthly) 0.61
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Apr 23, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.41
MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.
www.medadvisorsolutions.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: MDR.AX
Performance Overview: MDR.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDR.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDR.AX
Valuation Measures
Market Cap
162.30M
Enterprise Value
152.39M
Trailing P/E
--
Forward P/E
29.50
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.56
Price/Book (mrq)
2.91
Enterprise Value/Revenue
1.40
Enterprise Value/EBITDA
-124.53
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.25%
Return on Assets (ttm)
-2.39%
Return on Equity (ttm)
-15.21%
Revenue (ttm)
109.43M
Net Income Avi to Common (ttm)
-9.03M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
22.53M
Total Debt/Equity (mrq)
22.65%
Levered Free Cash Flow (ttm)
-4.18M
Research Analysis: MDR.AX
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: MDR.AX
MDR.AX does not have Company Insights